6-month benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of imPROve Asthma

Details

ISSN :

14388790

Database :

OpenAIRE

Journal :

63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.

Accession number :

edsair.doi...........eb945e4fcb82c9eabb24d6dd770d134f

Full Text :

https://doi.org/10.1055/s-0043-1761048